Online Office System

Journal Online

    column
    2022, 57(10):1-2.
    Abstract PDF
    2022, 57(10):1-4.
    Abstract PDF
    Integrated medicinal chemistry: new modalities and methodologies in drug discovery
    XU Shu-jing, DING Dang, LIU Xin-yong, ZHAN Peng
    2022, 57(10):2889-2901. DOI:10.16438/j.0513-4870.2022-0947
    Abstract PDF
    Research progress of small molecular drugs targeting RNA
    DU Xiao-li, CHEN Hui-hui, YE Xiang-yang, XIE Tian, HE Xing-rui
    2022, 57(10):2902-2913. DOI:10.16438/j.0513-4870.2022-0430
    Abstract PDF
    Research progress of small molecule inhibitors of doublecortin-like kinase 1
    CHEN Yu-ping, LI Ke-liang, SHENG Chun-quan, WU Shan-chao
    2022, 57(10):2914-2920. DOI:10.16438/j.0513-4870.2022-0649
    Abstract PDF
    Research progress on the G protein modulators
    YANG Yi-fan, HU Zhuo-rui, LIU He, LI Yi-xian, LIU Lu, XIONG Xiao-feng
    2022, 57(10):2921-2931. DOI:10.16438/j.0513-4870.2022-0656
    Abstract PDF
    Advances on Keap1-Nrf2 protein-protein interaction inhibitors and degraders
    YAN Jian-yu, LIU Guo-dong, MIAO Zhen-yuan, ZHUANG Chun-lin
    2022, 57(10):2932-2948. DOI:10.16438/j.0513-4870.2022-0669
    Abstract PDF
    Advances on clinical research of histone demethylase LSD1 inhibitors
    SHI Yu-ting, YANG Xin-yu, YU Bin, SONG Yi-hui
    2022, 57(10):2949-2959. DOI:10.16438/j.0513-4870.2022-0688
    Abstract PDF
    Research progress and medicinal chemistry strategies of URAT1 inhibitors
    SHI Xiao-yu, ZHAO Tong, ZHANG Jian, LIANG Rui-peng, ZHANG Zhi-jiao, LIU Xin-yong, ZHAN Peng
    2022, 57(10):2960-2971. DOI:10.16438/j.0513-4870.2022-0573
    Abstract PDF
    The recent advance of direct anti-HBV drug candidates in clinical trials
    WANG Mei, LIU Lin-yue, LI Chuan-ju, LIU Jun, JIA Hai-yong
    2022, 57(10):2972-2984. DOI:10.16438/j.0513-4870.2022-0318
    Abstract PDF
    Aspirin inhibits tumor cell metastasis mediated by HGF/c-Met
    DAI Xiao-yang, CHEN Si-kang, CHE Jin-xin
    2022, 57(10):2985-2994. DOI:10.16438/j.0513-4870.2022-0674
    Abstract PDF
    Screening and activity analysis of ZIKV RdRp inhibitors
    ZHANG Hong-juan, CHEN Ying, HAN Yan-xing, LIN Yuan, JIANG Jian-dong
    2022, 57(10):2995-3001. DOI:10.16438/j.0513-4870.2022-0701
    Abstract PDF
    Discovering BIX02189 as a novel anti-influenza virus compound using transcriptome signature reversion strategy
    WU You, CHEN Shu-bing, TANG Ke, GUO Ying
    2022, 57(10):3002-3010. DOI:10.16438/j.0513-4870.2022-0087
    Abstract PDF
    Virtual screening and activity study of antiviral compounds targeting inosine 5′-monophosphate dehydrogenase
    KOU Shi-bo, GAO Rong-mei, YI Hong, SUN Lian-qi, LI Yu-huan, LI Zhuo-rong
    2022, 57(10):3011-3018. DOI:10.16438/j.0513-4870.2022-0644
    Abstract PDF
    Discovery of a novel SARS-CoV-2 main protease inhibitor by a simple and optimized colorimetric screening assay
    YAN Gan-gan, YAN Hao-hao, LIU Zhi-cheng, QI Hai-yan, LIU Xiao-li, LIU Xiao-ping, ZHANG Jing, CHEN Yun-yu
    2022, 57(10):3019-3026. DOI:10.16438/j.0513-4870.2022-0365
    Abstract PDF
    Research progress on applying plant-derived natural calcium channel blockers in the antiarrhythmic drug development
    PU Li-hua, HE Shuang, ZHOU Zheng-can, ZHU Yan
    2022, 57(10):3027-3034. DOI:10.16438/j.0513-4870.2022-0284
    Abstract PDF
    Research progress on the pharmacodynamic mechanism of antidepressant compound prescriptions and its flavonoids active ingredients
    HAO Wen-zhi, WANG Lu, HUANG Jun-qing, CHEN Jia-xu
    2022, 57(10):3035-3046. DOI:10.16438/j.0513-4870.2022-0717
    Abstract PDF
    Research progress on pharmacological effects and clinical combined application of 3-n-butylphthalide in cerebrovascular diseases
    NI Wen-juan, LI Wei-xia, WANG Xiao-yan, WU Ya-li, HAN Bing, JIA Jin-hao, LI Kun, JI Qiu-ru, TANG Jin-fa
    2022, 57(10):3047-3056. DOI:10.16438/j.0513-4870.2022-0366
    Abstract PDF
    Research progress on the anti-dementia effect of Dipsaci Radix and its active compounds
    CUI Jin-shuai, LIU yan, WANG Zi-ying, CHENG Gang
    2022, 57(10):3057-3066. DOI:10.16438/j.0513-4870.2022-0729
    Abstract PDF
    Establishment of 3D organoids model of cardiac hypertrophy and its application in the mechanistic analysis of cardiovascular traditional Chinese medicine
    FAN Si-wen, ZHAO Yu-han, XIAO Guang-xu, FAN Guan-wei, ZHU Yan
    2022, 57(10):3067-3076. DOI:10.16438/j.0513-4870.2021-1756
    Abstract PDF
    Tanshinone I attenuates doxorubicin-induced cardiotoxicity based on the Akt-Nrf2 antioxidant pathway
    JIANG Qian-qian, ZHANG Jing-mei, XUE Si-ming, TIAN Xue, CHEN Xu, LIU Tian-tian, JIANG Yan-yan, SUN Qian-bin, GUO Dong-qing, LI Chun, WANG Yong, WANG Qi-yan
    2022, 57(10):3077-3085. DOI:10.16438/j.0513-4870.2021-1866
    Abstract PDF
    Construction of 3D blood-brain barrier organoid oxygen-glucose deprivation model and exploration of the protective effect of Guanxinning injection
    DU Hong-ying, XUE Zhi-feng, XIA Zhong-ting, HE Shuang, YANG Jian, ZHU Yan
    2022, 57(10):3086-3094. DOI:10.16438/j.0513-4870.2021-1871
    Abstract PDF
    Research of the mechanism of Chuanxiong Qingnao Granules in improving migraine based on network pharmacology and experimental validation
    HOU Jing-yi, NI Li-qi, TIAN Liang-liang, XU He, CAO Guang-zhao, WANG Kun, HOU Bo-wen, ZHANG Jing-jing, YANG Hong-jun
    2022, 57(10):3095-3105. DOI:10.16438/j.0513-4870.2022-0860
    Abstract PDF
    Higenamine attenuates isoproterenol-induced myocardial infarction via regulating METTL3/TFEB pathway
    XIE Bao-ping, GUO Yi-xin, YE Man-yi, HUANG Xu-can, LI Xu-ping, ZHONG Pei-cheng, WANG Da-wei, LIU Zhong-qiu, CHENG Yuan-yuan
    2022, 57(10):3106-3114. DOI:10.16438/j.0513-4870.2022-0435
    Abstract PDF
    The mechanism of ShengMaiSan reducing calcium leak and protecting myocardial contractile function in diabetic rats based on network pharmacology
    HUANG Cong, SUN Ming-jie, CUI Hai-feng, SUN Li-hua, WU QIAN, ZHAI Qu, SHI Xiao-lu
    2022, 57(10):3115-3123. DOI:10.16438/j.0513-4870.2022-0482
    Abstract PDF
    Research progress of the role of PPARγ in autoimmune diseases
    YANG Yan, ZHOU Yu, WEI Ya-zi, ZHANG Tian-tai
    2022, 57(10):3124-3132. DOI:10.16438/j.0513-4870.2022-0708
    Abstract
    Research progress of leukotriene B4 receptor antagonists
    ZHAO Tian-tian, SHEN Long-ying, PAN Xian-dao
    2022, 57(10):3133-3145. DOI:10.16438/j.0513-4870.2022-0602
    Abstract
    Recent advances in pharmacokinetic characteristics and physiological pharmacokinetic modeling of small interfering RNA (siRNA) drugs
    LI Qian, CHEN Rui, HU Pei
    2022, 57(10):3146-3156. DOI:10.16438/j.0513-4870.2022-0752
    Abstract
    The combined application of PBPK model and PopPK model in the dose selection of pediatric drug development: an example of rivaroxaban
    JIAN Wei-zhe, CHEN Rong, ZHOU Tian-yan
    2022, 57(10):3157-3162. DOI:10.16438/j.0513-4870.2022-0880
    Abstract
    A new patchoulane-type sesquiterpenoid from patchouli oil and its anti-inflammatory activity
    ZHANG Tian-hao, PENG Cheng, ZUO Jing, ZHENG Qi, MENG Chun-wang, GUO Li, ZHOU Qin-mei, XIONG Liang
    2022, 57(10):3163-3167. DOI:10.16438/j.0513-4870.2022-0514
    Abstract
    A new guaiane-sesquiterpenoid from the leaves of Chimonanthus nitens Oliv.
    GUO Na, WU Hua-qiang, SHU Ren-geng
    2022, 57(10):3168-3172. DOI:10.16438/j.0513-4870.2022-0623
    Abstract
    The mechanism of Isatidis Radix in the prevention of influenza and COVID-19 by HPLC-Q-TOF-MS combined with network pharmacology
    WANG Xing-qi, CHANG Jin, ZHANG Qian, LIN Li-na, SHAO Ping, LI Qing
    2022, 57(10):3173-3185. DOI:10.16438/j.0513-4870.2022-0455
    Abstract
    The antitussive and expectorant mechanisms of deapio-platycodin D as determined by metabolomics
    ZHONG Yuan-han, WANG Ling-long, QIU Zi-chao, ZHONG Shao-hui, WANG Xin-hong, ZENG Jin-xiang, ZHANG Xin-yu, LIU Fang-yuan, WANG Yu-jie, SUN Gen-lin, ZHOU Li-fen, WEI Guo-bing, ZHONG Guo-yue
    2022, 57(10):3186-3194. DOI:10.16438/j.0513-4870.2022-0521
    Abstract
    Identification of potential Q-markers of Semen Armeniacae Amarum based on UPLC-MS/MS and metabonomics
    CHENG Yao, BI Yue-lin, FENG Xin, WANG Jia-qi, XU Hao-ran, ZHANG Tong-hua, YU Geng-yuan, ZHANG Chen-ning, WANG Jing-hong, SUN Yi-kun
    2022, 57(10):3195-3202. DOI:10.16438/j.0513-4870.2022-0581
    Abstract
    Regulation of obeticholic acid on serum lipids and bile acids and gut microbiota of non-alcoholic steatohepatitis mice induced by methionine and choline deficiency diet
    WANG Wei, LUO Ping, MIAO Xiao-lei, ZENG Bei, WANG Jun-jun, CHEN Yong
    2022, 57(10):3203-3213. DOI:10.16438/j.0513-4870.2022-0624
    Abstract
    Rapid analysis and determination of the fragmentation regularity of phospholipids in human plasma based on UHPLC/Q-TOF-MS
    ZHONG Xun-long, WANG Ruo-lun, CHEN Li-shi, ZHONG Yan-mei
    2022, 57(10):3214-3222. DOI:10.16438/j.0513-4870.2022-0627
    Abstract PDF
    Determination of biological activity of human insulin by a homogeneous time-resolved fluorescence method
    WANG Lü-yin, YANG Yan-feng, ZHANG Xiao-ming, LÜ Ping, ZHANG Hui, LI Jing, LIANG Cheng-gang
    2022, 57(10):3223-3228. DOI:10.16438/j.0513-4870.2022-0641
    Abstract PDF
    Sequence structure and phylogenetic analysis of the chloroplast genomes of Alangium chinense (Lour.) Harms and its different subspecies
    YANG Xiao-ying, LIU Chang, ZENG Xian-fa, LIU Xiong-wei, ZHAO Jie-hong, FENG Ting-ting, ZHOU Ying
    2022, 57(10):3229-3239. DOI:10.16438/j.0513-4870.2022-0490
    Abstract PDF
    Characteristics and adaptive evolution analysis of the chloroplast genome of Gentiana rhodantha
    DENG Gang, WU Tian-ze, GAO Ran-ran, WANG Meng-yue, LIU Xia, XIANG Li
    2022, 57(10):3240-3253. DOI:10.16438/j.0513-4870.2022-0537
    Abstract PDF
    2022, 57(10):3254-3258. DOI:10.16438/j.0513-4870.2018-1026
    Abstract PDF

    Recommend